Fairvalue-Calculator Fairvalue-Calculator
EN DE

Keeps Biopharma Inc (256940) Fair Value & Analysis

Consumer Defensive · KR · Market cap 126B KRW

Price5,600 KRW
Fair Value5,559 KRW
Upside-0.7%
Quality83/100
Evidence: Medium Range 4,169 KRW – 6,949 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Keeps Biopharma Inc (256940) currently trades at 5,600 KRW, while our model-based Fair Value estimate is 5,559 KRW — implying the stock looks roughly 0.7% overvalued today. We read business quality at 83/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Open the full interactive analysis →

Similar stocks

The Procter & Gamble Company (PG) -45% L'Oréal S.A (LRLCF) -38% Unilever PLC (UNLYF) -22% Colgate-Palmolive Company (CPA) -30% Hindustan Unilever Limited (HINDUNILVR) -63% Reckitt Benckiser Group (RBGLY) +41%

Frequently asked questions

Is Keeps Biopharma Inc (256940) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 5,559 KRW versus a price of 5,600 KRW — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 256940?
Our 21-model fair value for Keeps Biopharma Inc is 5,559 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 5,600 KRW.
What is the quality score of 256940?
Keeps Biopharma Inc has a Quality Score of 83/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.